Company Overview of Adagio Pharmaceuticals Ltd.
Adagio Pharmaceuticals Ltd. owns and operates intellectual property relating to APL-130277, a reformulation of an approved Parkinson's drug. The company is based in Oakville, Canada. As of December 22, 2011, Adagio Pharmaceuticals Ltd. operates as a subsidiary of Cynapsus Therapeutics Inc.
1302 Kestell Boulevard
Oakville, ON L6H 0B9
Key Executives for Adagio Pharmaceuticals Ltd.
Adagio Pharmaceuticals Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Sandoz Canada Inc.||Americas|
|Allergan Inc. (Canada)||Americas|
|Cronus BioPharma Inc.||Americas|
|Mylan Pharmaceuticals ULC||Americas|
|Bioniche Animal Health Canada Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Adagio Pharmaceuticals Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.